# Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)

> **NCT01004718** · NA · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 10 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **RADIATION:** Fludeoxyglucose F18
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Positron emission tomography

## Key facts

- **NCT ID:** NCT01004718
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2013-07
- **Final completion:** 2014-11-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01004718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01004718, "Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01004718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*